A phase II trial of a TS-1 [S-1]/cisplatin based definitive chemoradiotherapy for resectable esophageal cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Apr 2014 Status changed from active, no longer recruiting to completed according to results published in the Cancer Chemotherapy and Pharmacology.
- 01 Aug 2011 Status changed from recruiting to active, no longer recruiting according to results published in the Cancer Chemotherapy and Pharmacology.